Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001181431-07-028334

Options or other derivatives

  • Sr. VP, Chief Business Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kollins John A Sr. VP, Chief Business Officer 2007-04-30 Grant or award · Option to Purchase Common Stock +200,000 200,000 D
Loading xslF345X02/rrd155430.xml…